Please ensure Javascript is enabled for purposes of website accessibility Skip to content
Section Navigation

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of the Pfizer- BioNTech’s COVID-19 vaccine for keiki ages 5-11. Pfizer’s data showed the vaccine is safe and 90 percent effective in preventing COVID-19 infections in this age group. Before vaccinations become available, the U.S. Centers for Disease Control and Prevention (CDC) will meet Nov. 2-3 to issue recommendations for clinical use of the vaccine. In preparation of this, we encourage parents and guardians to join us as we learn more about COVID-19 vaccinations for keiki and answer your questions!

Here are some helpful links from the presentation:

Mahalo for your interest and support; if you have appreciated the information in our COVID-19 webinar series, please consider donating to help us continue this work!

Note: Views expressed by panelists are their own and do not necessarily reflect Hawaiʻi Public Health Institute policies or positions. 

Back To Top